VICTORY CAPITAL MANAGEMENT INC - GENMARK DIAGNOSTICS INC ownership

GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 98 filers reported holding GENMARK DIAGNOSTICS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
VICTORY CAPITAL MANAGEMENT INC ownership history of GENMARK DIAGNOSTICS INC
ValueSharesWeighting
Q1 2021$227,000
-30.4%
9,499
-57.4%
0.00%
Q4 2020$326,000
-39.4%
22,322
-41.1%
0.00%
-100.0%
Q3 2020$538,000
+44.2%
37,874
+49.4%
0.00%0.0%
Q2 2020$373,000
+501.6%
25,345
+69.9%
0.00%
Q1 2020$62,000
+47.6%
14,918
+116.8%
0.00%
Q3 2019$42,000
+16.7%
6,880
-7.2%
0.00%
Q4 2018$36,000
-33.3%
7,4130.0%0.00%
Q3 2018$54,000
+31.7%
7,413
+15.1%
0.00%
Q2 2018$41,000
+17.1%
6,4390.0%0.00%
Q1 2018$35,000
+29.6%
6,4390.0%0.00%
Q4 2017$27,000
-56.5%
6,4390.0%0.00%
Q3 2017$62,000
-18.4%
6,4390.0%0.00%
Q2 2017$76,000
-6.2%
6,439
+1.7%
0.00%
Q1 2017$81,000
+5.2%
6,3290.0%0.00%
Q4 2016$77,000
+8.5%
6,329
+5.9%
0.00%
Q3 2016$71,000
+44.9%
5,977
+7.2%
0.00%
Q2 2016$49,000
+75.0%
5,578
+4.1%
0.00%
Q1 2016$28,000
-26.3%
5,359
+8.4%
0.00%
Q4 2015$38,000
+2.7%
4,944
+5.9%
0.00%
Q3 2015$37,000
-5.1%
4,670
+8.3%
0.00%
Q2 2015$39,0004,3120.00%
Other shareholders
GENMARK DIAGNOSTICS INC shareholders Q1 2018
NameSharesValueWeighting ↓
Casdin Capital, LLC 3,365,000$16,186,0001.49%
CADIAN CAPITAL MANAGEMENT, LP 5,517,767$26,540,0001.17%
NEEDHAM INVESTMENT MANAGEMENT LLC 1,590,000$7,646,0001.04%
Parkman Healthcare Partners LLC 420,000$2,020,0000.58%
Penn Capital Management Company, LLC 977,526$4,702,0000.49%
Bullseye Asset Management LLC 79,272$381,0000.37%
Bellevue Group AG 2,441,241$11,742,0000.19%
ESSEX INVESTMENT MANAGEMENT CO LLC 300,783$1,447,0000.18%
Granite Investment Partners, LLC 589,313$2,835,0000.13%
WRAPMANAGER INC 68,163$328,0000.10%
View complete list of GENMARK DIAGNOSTICS INC shareholders